TY  - JOUR
AU  - de la Espriella, Rafael
AU  - Bayés-Genís, Antoni
AU  - Morillas, Herminio
AU  - Bravo, Rafael
AU  - Vidal, Verónica
AU  - Núñez, Eduardo
AU  - Santas, Enrique
AU  - Miñana, Gema
AU  - Sanchis, Juan
AU  - Fácila, Lorenzo
AU  - Torres, Francisco
AU  - Górriz, Jose Luis
AU  - Valle, Alfonso
AU  - Núñez, Julio
PY  - 2020
DO  - 10.1002/ehf2.12965
UR  - https://hdl.handle.net/10668/26643
T2  - ESC heart failure
AB  - The aim of this study was to evaluate the safety profile in terms of changes in renal function after co-treatment with sacubitril/valsartan and empagliflozin in patients with type 2 diabetes (T2D) and heart failure with reduced ejection fraction...
LA  - en
KW  - Heart failure with reduced ejection fraction (HFrEF)
KW  - Renal function
KW  - Renal safety profile
KW  - SGLT2i
KW  - Sacubitril/valsartan
KW  - Type 2 diabetes mellitus
TI  - Renal function dynamics following co-administration of sacubitril/valsartan and empagliflozin in patients with heart failure and type 2 diabetes.
TY  - research article
VL  - 7
ER  -